These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20378714)

  • 21. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML; Schenck KW; Hemrick-Luecke SH
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
    Jeong CY; Choi JI; Yoon MH
    Eur J Pharmacol; 2004 Oct; 502(3):205-11. PubMed ID: 15476746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries.
    Deckert V; Pruneau D; Elghozi JL
    Br J Pharmacol; 1994 Jul; 112(3):939-45. PubMed ID: 7921624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
    Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
    Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
    Cohen ML; Schenck K
    J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naftopidil inhibits 5-hydroxytryptamine-induced bladder contraction in rats.
    Sakai T; Kasahara K; Tomita K; Ikegaki I; Kuriyama H
    Eur J Pharmacol; 2013 Jan; 700(1-3):194-200. PubMed ID: 23274492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.
    Russell A; Banes A; Berlin H; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):179-87. PubMed ID: 12235249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists.
    Vickers SP; Easton N; Malcolm CS; Allen NH; Porter RH; Bickerdike MJ; Kennett GA
    Pharmacol Biochem Behav; 2001; 69(3-4):643-52. PubMed ID: 11509227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of sensitivity to 5-hydroxytryptamine in pulmonary supernumerary but not conventional arteries by a 5-HT(1D)-like receptor.
    Shaw AM; Bunton DC; Brown T; Irvine J; MacDonald A
    Eur J Pharmacol; 2000 Nov; 408(1):69-82. PubMed ID: 11070185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
    McCreary AC; Bankson MG; Cunningham KA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
    Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
    Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery.
    Molderings GJ; Engel G; Roth E; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):300-8. PubMed ID: 2812041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of 5-hydroxytryptamine receptors on the isolated pig basilar artery by functional and radioligand binding studies.
    Miyamoto A; Sakota T; Nishio A
    Jpn J Pharmacol; 1994 Jul; 65(3):265-73. PubMed ID: 7799527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
    Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of Serotonin Receptors Causing Contraction of Isolated Bovine Posterior Ciliary Arteries: Role in Ocular Blood Flow.
    Njie-Mbye YF; Robinson J; Mitchell-Bush L; Mckoy M; Opere CA; Ohia SE; Sharif N
    J Ocul Pharmacol Ther; 2018; 34(1-2):134-140. PubMed ID: 29369737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The actions of 5-hydroxytryptamine receptor agonists and antagonists at pre- and postjunctional level on the canine saphenous vein.
    Paiva MQ; Caramona MM; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):616-22. PubMed ID: 2977424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional serotonin 5-HT1D receptors and 5-HT1D beta receptor mRNA expression in human umbilical vein endothelial cells.
    Schoeffter P; Ullmer C; Gutierrez M; Weitz-Schmidt G; Lübbert H
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):580-2. PubMed ID: 8751089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.